| MNPR |
MONOPAR THERAPEUTICS INC |
Common Stock |
19.5% |
$105M |
$9.39M |
1.29M |
+9.81% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| DRUG |
BRIGHT MINDS BIOSCIENCES INC. |
Common Stock |
16.3% |
$28.4M |
$851K |
1.15M |
+3.09% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| CMPR |
CIMPRESS PLC |
Common Stock |
13.7% |
$211M |
$2.03M |
3.35M |
+0.97% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| VTGN |
VISTAGEN THERAPEUTICS, INC. |
Common Stock |
13.6% |
$13.3M |
|
4.17M |
|
JANUS HENDERSON GROUP PLC |
29 Aug 2025 |
| CCSI |
Consensus Cloud Solutions, Inc. |
Common Stock |
13.1% |
$72.7M |
-$1.31M |
2.48M |
-1.77% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| PRAX |
PRAXIS PRECISION MEDICINES, INC |
Common Stock |
12.3% |
$146M |
$12.2M |
2.76M |
+9.1% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| ENTA |
ENANTA PHARMACEUTICALS INC |
Common Stock |
12.1% |
$41.8M |
|
3.49M |
|
JANUS HENDERSON GROUP PLC |
31 Oct 2025 |
| IVVD |
INVIVYD, INC. |
Common Stock |
12.1% |
$27.9M |
$1.22M |
25.4M |
+4.58% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| TVTX |
TRAVERE THERAPEUTICS, INC |
Common Stock |
11.9% |
$253M |
-$17.7M |
10.6M |
-6.53% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| SLNO |
SOLENO THERAPEUTICS, INC. |
Common Stock |
11.4% |
$409M |
$50.6M |
6.06M |
+14.1% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| WEX |
WEX, Inc. |
Common Stock |
11.3% |
$569M |
-$20.3M |
3.87M |
-3.44% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| TARA |
PROTARA THERAPEUTICS, INC. |
Common Stock |
11% |
$18.4M |
$560K |
4.23M |
+3.14% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| MIRM |
MIRUM PHARAMACEUTICALS, INC. |
Common Stock |
10.6% |
$388M |
$31.9M |
5.45M |
+8.95% |
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| DYN |
DYNE THERAPEUTICS INC |
Common Stock |
10.4% |
$187M |
$4.43M |
14.7M |
+2.43% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| SGRY |
SURGERY PARTNERS, INC. |
Common Stock |
10.2% |
$282M |
$1.77M |
13M |
+0.63% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| MREO |
MEREO BIOPHARMA GROUP PLC |
American Depositary Shares |
10.2% |
$33.6M |
-$2.88M |
16.3M |
-7.91% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| PCVX |
VAXCYTE, INC. |
Common Stock |
10.1% |
$472M |
-$57.2M |
13.1M |
-10.8% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| ICUI |
ICU MEDICAL, INC. |
Common Stock |
10% |
$326M |
$272K |
2.47M |
+0.08% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| JANX |
JANUX THERAPEUTICS, INC. |
Common Stock |
10% |
$147M |
$38.5M |
6.03M |
+35.3% |
JANUS HENDERSON GROUP PLC |
31 Oct 2025 |
| LXEO |
LEXEO THERAPEUTICS, INC. |
Common Stock |
9.99% |
$65.9M |
$10.7M |
7.29M |
+19.4% |
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| BNTC |
BENITEC BIOPHARMA INC. |
Common Stock |
9.99% |
$44.5M |
-$292M |
3.38M |
-86.8% |
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| PALI |
PALISADE BIO, INC. |
Common Stock |
9.99% |
$27.8M |
|
14.9M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| INO |
INOVIO PHARMACEUTICALS, INC. |
Common Stock |
9.99% |
$13M |
$6.63M |
6.67M |
+104% |
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| OVID |
OVID THERAPEUTICS INC. |
Common Stock |
9.99% |
$9.46M |
|
7.11M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| EQ |
EQUILLIUM, INC. |
Common Stock |
9.99% |
$8.76M |
|
6.08M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| IMUX |
IMMUNIC, INC. |
Common Stock |
9.99% |
$8.53M |
$6.62M |
12M |
+347% |
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| KTTA |
PASITHEA THERAPEUTICS CORP. |
Common Stock |
9.99% |
$7.16M |
|
10.2M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| TENX |
TENAX THERAPEUTICS, INC. |
Common Stock |
9.99% |
$4.17M |
$3.06M |
624K |
+274% |
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| PTNT |
PALATIN TECHNOLOGIES INC |
Common Stock |
9.99% |
$1.3M |
|
170K |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| FBRX |
FORTE BIOSCIENCES, INC. |
Common Stock |
9.9% |
$6.94M |
|
658K |
0% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| LNTH |
LANTHEUS HOLDINGS, INC. |
Common Stock |
9.8% |
$343M |
-$13M |
6.68M |
-3.66% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| TFX |
TELEFLEX INCORPORATED |
Common Stock |
9.4% |
$497M |
-$21.2M |
4.15M |
-4.09% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| ZD |
ZIFF DAVIS, INC. |
Common Stock |
8.4% |
$131M |
-$4.95M |
3.44M |
-3.64% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Common Stock |
8.3% |
$845M |
-$160M |
1.84M |
-15.9% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| ASMB |
ASSEMBLY BIOSCIENCES, INC. |
Common Stock |
8.2% |
$44.4M |
|
1.34M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| AKRO |
AKERO THERAPEUTICS, INC. |
Ordinary Shares |
7.9% |
$298M |
-$21.8M |
6.28M |
-6.8% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| ASND |
ASCENDIS PHARMA A/S |
American Depositary Shares |
7.8% |
$859M |
-$20.8M |
4.32M |
-2.37% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| GPCR |
STRUCTURE THERAPEUTICS INC |
American Depositary Shares |
7.7% |
$125M |
-$3.48M |
4.45M |
-2.72% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Common Stock |
7.7% |
$113M |
-$56.5M |
7.43M |
-33.3% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| IDYA |
IDEAYA BIOSCIENCES, INC. |
Common Stock |
7.3% |
$175M |
$6.04M |
6.43M |
+3.58% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| MAZE |
MAZE THERAPEUTICS, INC. |
Common Stock |
7.3% |
$83.1M |
$15.1M |
3.21M |
+22.1% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| FLEX |
FLEX LTD. |
Ordinary Shares |
7% |
$1.53B |
-$10M |
26.3M |
-0.65% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| GIL |
GILDAN ACTIVEWEAR INC |
Common Stock |
7% |
$607M |
$33.1M |
10.5M |
+5.78% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| ARMK |
ARAMARK |
Common Stock |
6.9% |
$784M |
$62.5M |
18M |
+8.67% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| ST |
SENSATA TECHNOLOGIES HOLDING PLC |
Ordinary Shares |
6.9% |
$307M |
$2.67M |
10.1M |
+0.88% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| SSNC |
SS&C TECHNOLOGIES HOLDINGS, INC. |
Common Stock |
6.8% |
$1.47B |
$3.68M |
16.5M |
+0.25% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| RVTY |
REVVITY, INC. |
American Depositary Shares |
6.6% |
$669M |
$35.5M |
7.63M |
+5.62% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| BHVN |
BIOHAVEN LTD. |
Common Stock |
6.4% |
$102M |
$25.8M |
6.77M |
+34% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| RVMD |
REVOLUTION MEDICINES, INC. |
Common Stock |
6.1% |
$530M |
$35.7M |
11.4M |
+7.23% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| GMED |
GLOBUS MEDICAL, INC. |
Class A Common Stock |
6.1% |
$522M |
$30.8M |
7.03M |
+6.27% |
JANUS HENDERSON GROUP PLC |
31 Mar 2025 |
| ASUR |
ASURE SOFTWARE INC |
Class A Common Stock |
6.1% |
$13.8M |
-$317K |
1.68M |
-2.25% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| DAY |
DAYFORCE, INC. |
Common Stock |
6% |
$647M |
$69.8M |
9.4M |
+12.1% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| OCGN |
OCUGEN, INC. |
Common Stock |
6% |
$26.8M |
|
20M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| OSIS |
OSI SYSTEMS, INC. |
Common Stock |
5.9% |
$249M |
-$13.1M |
1M |
-4.98% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| ARDX |
ARDELYX, INC. |
Common Stock |
5.7% |
$76.2M |
-$6.8M |
13.8M |
-8.19% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
|
RENTOKIL INITIAL PLC |
Common Stock |
5.6% |
|
-$2.24M |
142M |
-0.31% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| RNA |
AVIDITY BIOSCIENCES, INC. |
Common Stock |
5.5% |
$583M |
-$446M |
8.22M |
-43.4% |
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| SXT |
SENSIENT TECHNOLOGIES CORPORATION |
Common Stock |
5.4% |
$215M |
-$4.37M |
2.29M |
-2% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| TYRA |
TYRA BIOSCIENCES, INC |
Common Stock |
5.4% |
$29.3M |
$1.67M |
2.86M |
+6.05% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| APG |
API GROUP CORP |
Common Stock |
5.3% |
$764M |
|
22.2M |
|
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| LGND |
LIGAND PHARMACEUTICALS INCORPORATED |
Common Stock |
5.3% |
$185M |
-$3.25M |
1.04M |
-1.73% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| OLMA |
OLEMA PHARMACEUTICALS, INC. |
Common Stock |
5.2% |
$35.1M |
|
3.59M |
|
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| MTSR |
METSERA, INC. |
Common Stock |
5.1% |
$280M |
|
5.35M |
|
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| XENE |
XENON PHARMACEUTICALS INC. |
Common Stock |
5.1% |
$158M |
|
3.94M |
|
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| BMEA |
BIOMEA FUSION, INC. |
Common Stock |
5% |
$4.73M |
|
3.75M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| INSE |
INSPIRED ENTERTAINMENT, INC |
Common Stock |
4.9% |
$12.4M |
-$285K |
1.32M |
-2.24% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| FDMT |
4D Molecular Therapeutics, Inc. |
Common Stock |
4.9% |
$7.32M |
|
2.25M |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
| FWONK |
LIBERTY MEDIA CORPORATION |
Series C Liberty Formula One Common Stock |
4.8% |
$1.12B |
-$292M |
10.7M |
-20.7% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| NEO |
NEOGENOMICS INC |
Common Stock |
4.8% |
$63.3M |
|
6.17M |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
| EWTX |
EDGEWISE THERAPEUTICS, INC. |
Common Stock |
4.7% |
$80.8M |
-$8.5M |
4.98M |
-9.52% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| WD |
WALKER & DUNLOP, INC. |
Common Stock |
4.6% |
$110M |
-$21.3M |
1.56M |
-16.2% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| SKIN |
The Beauty Health Company |
Common Stock |
4.5% |
$10.9M |
-$4.85M |
5.72M |
-30.8% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| BLKB |
BLACKBAUD, INC. |
Common Stock |
4.3% |
$135M |
-$48.6M |
2.12M |
-26.4% |
JANUS HENDERSON GROUP PLC |
31 Mar 2025 |
| TRDA |
ENTRADA THERAPEUTICS, INC. |
Common Stock |
4% |
$9.96M |
-$3.93M |
1.52M |
-28.3% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| ETNB |
89bio, Inc. |
Common Stock |
3.6% |
$79.1M |
-$227M |
5.38M |
-74.1% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
|
ZAI LAB LTD |
Common Stock |
3.6% |
|
|
39.5M |
-41% |
JANUS HENDERSON GROUP PLC |
31 Mar 2025 |
| CZR |
CAESARS ENTERTAINMENT INC |
Common Stock |
3.3% |
$199M |
|
7.1M |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
|
DBV TECHNOLOGIES S.A. |
Common Stock |
2.6% |
|
|
5.27M |
|
JANUS HENDERSON GROUP PLC |
28 Nov 2025 |
| DOX |
AMDOCS LIMITED |
Ordinary Shares |
2.3% |
$204M |
-$271M |
2.49M |
-57.1% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| IMNM |
IMMUNOME INC |
Common Stock |
2.2% |
$16.3M |
-$13.1M |
1.91M |
-44.6% |
JANUS HENDERSON GROUP PLC |
31 Mar 2025 |
| PEPG |
PEPGEN INC |
Common Stock |
1.6% |
$836K |
|
522K |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
| VRNA |
VERONA PHARMA PLC |
American Depositary Shares |
1.2% |
$108M |
-$547M |
1.01M |
-83.5% |
JANUS HENDERSON GROUP PLC |
30 Sep 2025 |
| OABI |
OMNIAB, INC. |
Common Stock |
0.8% |
$2.09M |
-$15.7M |
948K |
-88.2% |
JANUS HENDERSON GROUP PLC |
30 Jun 2025 |
| CATX |
PERSPECTIVE THERAPEUTICS INC |
Common Stock |
0% |
$43.3K |
|
17.8K |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
| CRGX |
CARGO THERAPEUTICS, INC. |
Common Stock |
0% |
$36.6K |
-$13.1M |
7.9K |
-99.7% |
JANUS HENDERSON GROUP PLC |
31 Mar 2025 |
| APLT |
APPLIED THERAPEUTICS INC |
Common Stock |
0% |
$14K |
-$4.71M |
35.8K |
-99.7% |
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
| LRMR |
LARIMAR THERAPEUTICS, INC. |
Common Stock |
0% |
$0 |
-$22.4M |
0 |
-100% |
JANUS HENDERSON GROUP PLC |
31 Mar 2025 |
| NGNE |
NEUROGENE INC. |
Common Stock |
0% |
$0 |
|
0 |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
| DTIL |
Precision BioSciences, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |
| CTMX |
CytomX Therapeutics, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
JANUS HENDERSON GROUP PLC |
31 Dec 2024 |